Compare VIR & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | IDT |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 773.5M | 1.2B |
| IPO Year | 2019 | 1996 |
| Metric | VIR | IDT |
|---|---|---|
| Price | $6.78 | $52.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $25.73 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 158.8K |
| Earning Date | 11-05-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 0.47% |
| EPS Growth | N/A | ★ 10.35 |
| EPS | N/A | ★ 3.22 |
| Revenue | $16,860,000.00 | ★ $1,244,681,000.00 |
| Revenue This Year | N/A | $0.77 |
| Revenue Next Year | $48.05 | N/A |
| P/E Ratio | ★ N/A | $16.19 |
| Revenue Growth | N/A | ★ 2.52 |
| 52 Week Low | $4.16 | $44.77 |
| 52 Week High | $14.45 | $71.12 |
| Indicator | VIR | IDT |
|---|---|---|
| Relative Strength Index (RSI) | 61.51 | 58.08 |
| Support Level | $6.49 | $47.30 |
| Resistance Level | $6.89 | $53.99 |
| Average True Range (ATR) | 0.47 | 1.76 |
| MACD | 0.06 | 0.31 |
| Stochastic Oscillator | 83.17 | 70.40 |
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.